Assessing the determinants of durable protective immunity in SARS-CoV-2 infected human subjects
While natural immunity from a primary infection stands as our only barrier against reinfection, to date no study has determined if a primary infection generates long-lived durable anti-SARS-CoV-2 adaptive immunity. To this end, our studies will examine innate immune responses in SARS-CoV-2 infected individuals to understand how this first wave of immunity shapes protective immune responses against re-infection.